This page shows the publications co-authored by George Tsokos and Abhigyan Satyam.
Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19. Clin Immunol. 2021 05; 226:108716.
Curb complement to cure COVID-19. Clin Immunol. 2020 12; 221:108603.
Cell derived extracellular matrix-rich biomimetic substrate supports podocyte proliferation, differentiation and maintenance of native phenotype. Adv Funct Mater. 2020 Oct 28; 30(44).
Complement Deposition on the Surface of RBC After Trauma Serves a Biomarker of Moderate Trauma Severity: A Prospective Study. Shock. 2020 01; 53(1):16-23.
Complement and coagulation cascades in trauma. Acute Med Surg. 2019 Oct; 6(4):329-335.
Intracellular Activation of Complement 3 Is Responsible for Intestinal Tissue Damage during Mesenteric Ischemia. J Immunol. 2017 01 15; 198(2):788-797.
Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19. Clin Immunol. 2021 08; 229:108795.
C3a Enhances the Formation of Intestinal Organoids through C3aR1. Front Immunol. 2017; 8:1046.
A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury. Cell Rep Med. 2020 Nov 17; 1(8):100137.
A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic. bioRxiv. 2020 Jun 30.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.